Table 1. HPV/VIA results stratified by cytology and colposcopy results among 1193 women with a valid HPV test, VIA test and cytology.
| Cytology | Colpo not done | Negative | CIN1 | CIN2 | CIN3 | ICC | Total |
| N (VIA+, HPV+) | N (VIA+, HPV+) | N (VIA+, HPV+) | N (VIA+, HPV+) | N (VIA+, HPV+) | N (VIA+, HPV+) | N (VIA+%, HPV+ %) | |
| Negative (N = 321) | 207 (7 ,50) | 53 (17 ,19) | 55 (30 ,22) | 6 (4 ,3) | 0 (0 ,0) | 0 (0 ,0) | 321 (18.1%, 29.3%) |
| ASCUS (N = 31) | 2 (0 ,1) | 3 (0 ,1) | 24 (5 ,5) | 2 (0 ,2) | 0 (0 ,0) | 0 (0 ,0) | 31 (16.1%, 29.0%) |
| LSIL (N = 442) | 21 (8 ,13) | 24 (5 ,9) | 338 (127 ,187) | 54 (36 ,44) | 5 (3 ,5) | 0 (0 ,0) | 442 (40.5%, 58.4%) |
| ASC-H (N = 30) | 3 (2 ,1) | 2 (0 ,0) | 18 (3 ,9) | 4 (2 ,4) | 3 (1 ,3) | 0 (0 ,0) | 30 (26.7%, 56.7%) |
| HSIL (N = 367) | 19 (15 ,18) | 4 (1 ,3) | 109 (67 ,98) | 142 (121 ,137) | 91 (71 ,89) | 2 (2 ,2) | 367 (75.5%, 94.6%) |
| SCC (N = 2) | 0 (0 ,0) | 0 (0 ,0) | 1 (0 ,1) | 0 (0 ,0) | 1 (1 ,1) | 0 (0 ,0) | 2 (50.0%, 100.0%) |
| Total (N = 1193) | 252 (32 ,83) | 86 (23 ,32) | 545 (232 ,322) | 208(163,190) | 100 (76,98) | 2 (2 ,2) | 1193 (44.3%, 60.9%) |
Cytology = Cytology Pap smear, HPV = HPV DNA, VIA = Visual inspection with 5% acetic acid, LSIL = Low grade squamous intra-epithelial lesions, ASCUS = Atypical squamous cells of underdetermined significance, HSIL = High grade squamous intra-epithelial lesions, ASC-H = Atypical squamous cells cannot excluded high grade lesion, SCC = Squamous cell carcinoma, CIN1 = Cervical intraepithelial neoplasia grade 1, CIN2 = Cervical intraepithelial neoplasia grade 2, CIN3 = Cervical intraepithelial neoplasia grade 3, ICC = Invasive cervical cancer.